Marie Onyamboko
Overview
Explore the profile of Marie Onyamboko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
635
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Onyamboko M, Wasakul V, Bakomba S, Kayembe D, Nzambiwishe B, Ekombolo P, et al.
Lancet Glob Health
. 2025 Feb;
13(3):e479-e487.
PMID: 40021306
Background: Genomic surveillance is a valuable tool for detecting changes in the drug susceptibility of malaria parasites, enabling timely adjustments to treatment strategies. However, implementation can be costly and challenging...
2.
Fanello C, Lee S, Bancone G, Kayembe D, Ndjowo P, Badjanga B, et al.
Am J Trop Med Hyg
. 2023 Sep;
109(4):965-974.
PMID: 37669757
Neonatal hyperbilirubinemia (NH) is a frequent condition that, if left untreated, can lead to neurological disability and death. We assessed the prevalence of NH and associated neonatal and maternal risk...
3.
Watson J, Warsame M, Peto T, Onyamboko M, Fanello C, Dondorp A, et al.
BMJ Glob Health
. 2022 Jul;
7(7).
PMID: 35831037
No abstract available.
4.
Jacob C, Thuy-Nhien N, Mayxay M, Maude R, Quang H, Hongvanthong B, et al.
Elife
. 2021 Aug;
10.
PMID: 34372970
Background: National Malaria Control Programmes (NMCPs) currently make limited use of parasite genetic data. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion...
5.
van der Pluijm R, Tripura R, Hoglund R, Phyo A, Lek D, Ul Islam A, et al.
Lancet
. 2020 Mar;
395(10233):1345-1360.
PMID: 32171078
Background: Artemisinin and partner-drug resistance in Plasmodium falciparum are major threats to malaria control and elimination. Triple artemisinin-based combination therapies (TACTs), which combine existing co-formulated ACTs with a second partner...
6.
Taylor W, Naw H, Maitland K, Williams T, Kapulu M, DAlessandro U, et al.
BMC Med
. 2018 Jan;
16(1):11.
PMID: 29347975
Background: In 2012, the World Health Organization recommended blocking the transmission of Plasmodium falciparum with single low-dose primaquine (SLDPQ, target dose 0.25 mg base/kg body weight), without testing for glucose-6-phosphate...
7.
Miotto O, Amato R, Ashley E, MacInnis B, Almagro-Garcia J, Amaratunga C, et al.
Nat Genet
. 2015 Jan;
47(3):226-34.
PMID: 25599401
We report a large multicenter genome-wide association study of Plasmodium falciparum resistance to artemisinin, the frontline antimalarial drug. Across 15 locations in Southeast Asia, we identified at least 20 mutations...
8.
Chomba E, Tshefu A, Onyamboko M, Kaseba-Sata C, Moore J, McClure E, et al.
Acta Obstet Gynecol Scand
. 2010 Mar;
89(4):531-539.
PMID: 20230310
Objective: To study pregnant women's knowledge, attitudes and behaviors towards tobacco use and secondhand smoke (SHS) exposure, and exposure to advertising for and against tobacco products in Zambia and the...
9.
Kadir M, McClure E, Goudar S, Garces A, Moore J, Onyamboko M, et al.
Acta Obstet Gynecol Scand
. 2009 Dec;
89(4):540-548.
PMID: 19961275
Objective: We studied exposure to solid fuel and second-hand tobacco smoke among pregnant women in south Asia, Africa and Latin America. Design: Prospective cross-sectional survey. Setting: Antenatal clinics in Argentina,...
10.
Bloch M, Althabe F, Onyamboko M, Kaseba-Sata C, Castilla E, Freire S, et al.
Am J Public Health
. 2008 Mar;
98(10):1833-40.
PMID: 18309125
Objectives: We examined pregnant women's use of cigarettes and other tobacco products and the exposure of pregnant women and their young children to secondhand smoke (SHS) in 9 nations in...